{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:08:30Z","timestamp":1794049710481,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Thailand Science Research and Innovation Fund Chulalongkorn University","award":["CU_FRB65_hea (1)_007_32_02"],"award-info":[{"award-number":["CU_FRB65_hea (1)_007_32_02"]}]},{"name":"Thailand Science Research and Innovation Fund Chulalongkorn University","award":["CU_FRB65_hea (1)_007_32_02"],"award-info":[{"award-number":["CU_FRB65_hea (1)_007_32_02"]}]},{"name":"Thailand Science Research and Innovation Fund Chulalongkorn University","award":["CU_FRB65_hea (1)_007_32_02"],"award-info":[{"award-number":["CU_FRB65_hea (1)_007_32_02"]}]},{"name":"Thailand Science Research and Innovation Fund Chulalongkorn University","award":["CU_FRB65_hea (1)_007_32_02"],"award-info":[{"award-number":["CU_FRB65_hea (1)_007_32_02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although topical steroids constitute the first-line therapy for recurrent aphthous ulcers (RAUs), their long-term use often leads to candidiasis. Although cannabidiol (CBD) can be an alternative for pharmacologically managing RAUs due to its analgesic and anti-inflammatory in vivo effects, there is a lack of clinical and safety trials concerning its use. The aim of this study was to evaluate the clinical safety and efficacy of topical 0.1% CBD for managing RAU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A CBD patch test was performed on 100 healthy subjects. CBD was applied on the normal oral mucosa of 50 healthy subjects 3 times\/day for 7\u00a0days. Oral examination, vital signs, and blood tests were performed pre- and post-CBD use. Another 69 RAU subjects randomly received one of three topical interventions: 0.1% CBD, 0.1% triamcinolone acetonide (TA), or placebo. These were applied on the ulcers 3 times\/day for 7\u00a0days. The ulcer and erythematous size were measured on day 0, 2, 5, and 7. Pain ratings were recorded daily. The subjects rated their satisfaction with the intervention and completed a quality-of-life questionnaire (OHIP-14).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>None of the subjects exhibited allergic reactions or side effects. Their vital signs and blood parameters were stable before and after the 7-day CBD intervention. CBD and TA significantly reduced ulcer size more than placebo at all time points. The erythematous size reduction was higher in the CBD intervention than the placebo on day 2, while TA reduced the erythematous size at all time points. The pain score in the CBD group was lower compared with placebo on day 5, whereas TA reduced pain more than placebo on day 4, 5, and 7. The subjects receiving CBD reported higher satisfaction than placebo. However, the OHIP-14 scores were comparable among the interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Topical 0.1% CBD reduced ulcer size and accelerated ulcer healing without side effects. CBD exerted anti-inflammatory effects in the early stage and an analgesic effect in the late RAU stage. Thus, topical 0.1% CBD might be more appropriate for RAU patients who decline to take topical steroids, except for cases where CBD is contraindicated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Thai Clinical Trials Registry (TCTR) Number TCTR20220802004. Retrospectively registered on 02\/08\/2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-03886-0","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:03:47Z","timestamp":1676883827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Chalapinyo","family":"Umpreecha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokporn","family":"Bhalang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusadee","family":"Charnvanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jittima","family":"Luckanagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"3886_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cden.2013.12.002","volume":"58","author":"SO Akintoye","year":"2014","unstructured":"Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. 2014;58:281\u201397.","journal-title":"Dent Clin North Am"},{"key":"3886_CR2","doi-asserted-by":"publisher","first-page":"21181","DOI":"10.1038\/s41598-020-78281-7","volume":"10","author":"B Cheng","year":"2020","unstructured":"Cheng B, Zeng X, Liu S, Zou J, Wang Y. The efficacy of probiotics in management of recurrent aphthous stomatitis: a systematic review and meta-analysis. Sci Rep. 2020;10:21181.","journal-title":"Sci Rep"},{"key":"3886_CR3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.medcli.2016.12.031","volume":"149","author":"A Rodriguez-Archilla","year":"2017","unstructured":"Rodriguez-Archilla A, Raissouni T. Randomized clinical trial of the effectiveness of complementary therapies for recurrent aphthous stomatitis. Med Clin (Barc). 2017;149:55\u201360.","journal-title":"Med Clin (Barc)"},{"key":"3886_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00005-011-0134-1","volume":"59","author":"N Lewkowicz","year":"2011","unstructured":"Lewkowicz N, Kur B, Kurnatowska A, Tchorzewski H, Lewkowicz P. Expression of Th1\/Th2\/Th3\/Th17-related genes in recurrent aphthous ulcers. Arch Immunol Ther Exp (Warsz). 2011;59:399\u2013406.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"3886_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/0973-029X.86669","volume":"15","author":"L Preeti","year":"2011","unstructured":"Preeti L, Magesh K, Rajkumar K, Karthik R. Recurrent aphthous stomatitis. J Oral Maxillofac Pathol. 2011;15:252\u20136.","journal-title":"J Oral Maxillofac Pathol"},{"key":"3886_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1601-0825.2005.01143.x","volume":"12","author":"S Jurge","year":"2006","unstructured":"Jurge S, Kuffer R, Scully C, Porter SR. Mucosal disease series. number VI. recurrent aphthous stomatitis. Oral Dis. 2006;12:1\u201321.","journal-title":"Oral Dis"},{"key":"3886_CR7","first-page":"242","volume":"7","author":"A Altenburg","year":"2009","unstructured":"Altenburg A, Krahl D, Zouboulis C. Non-infectious ulcerating oral mucous membrane diseases. J Dtsch Dermatol Ges. 2009;7:242\u201357.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3886_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ajhp\/58.1.41","volume":"58","author":"RW Barrons","year":"2001","unstructured":"Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm. 2001;58:41\u201350.","journal-title":"Am J Health Syst Pharm"},{"key":"3886_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4317\/jced.51401","volume":"6","author":"I Belenguer-Guallar","year":"2014","unstructured":"Belenguer-Guallar I, Jimenez-Soriano Y, Claramunt-Lozano A. Treatment of recurrent aphthous stomatitis. a literature review. J Clin Exp Dent. 2014;6:168\u201374.","journal-title":"J Clin Exp Dent"},{"key":"3886_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/2229-5178.142483","volume":"5","author":"A Coondoo","year":"2014","unstructured":"Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: a long overdue revisit. Indian Dermatol Online J. 2014;5:416\u201325.","journal-title":"Indian Dermatol Online J"},{"key":"3886_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","volume":"9","author":"S Vuckovic","year":"2018","unstructured":"Vuckovic S, Srebro D, Vujovic KS, Vucetic C, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259.","journal-title":"Front Pharmacol"},{"key":"3886_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","volume":"556","author":"B Costa","year":"2007","unstructured":"Costa B, Trovato A, Comelli F. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007;556:75\u201383.","journal-title":"Eur J Pharmacol"},{"key":"3886_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/08923973.2014.976794","volume":"37","author":"A Ribeiro","year":"2015","unstructured":"Ribeiro A, Almeida VI, Costola-de-Souza C, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, et al. Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury. Immunopharmacol Immunotoxicol. 2015;37:35\u201341.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"3886_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.108.147181","volume":"328","author":"H Pan","year":"2009","unstructured":"Pan H, Mukhopadhyay P, Rajesh M, Patel V, Mukhopadhyay B, Gao B, et al. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther. 2009;328:708\u201314.","journal-title":"J Pharmacol Exp Ther"},{"key":"3886_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2014.11.001","volume":"76","author":"A Kasuya","year":"2014","unstructured":"Kasuya A, Tokura Y. Attempts to accelerate wound healing. J Dermatol Sci. 2014;76:169\u201372.","journal-title":"J Dermatol Sci"},{"key":"3886_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lfs.2016.04.033","volume":"155","author":"LA Brizeno","year":"2016","unstructured":"Brizeno LA, Assreuy AM, Alves AP, Sousa FB, Silva PG, Sousa SC, et al. Delayed healing of oral mucosa in a diabetic rat model: implication of TNF-alpha, IL-1beta and FGF-2. Life Sci. 2016;155:36\u201347.","journal-title":"Life Sci"},{"key":"3886_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1590\/1678-775720150481","volume":"24","author":"BV Oliveira","year":"2016","unstructured":"Oliveira BV, Barros Silva PG, Nojosa Jde S, Brizeno LA, Ferreira JM, Sousa FB, et al. TNF-alpha expression, evaluation of collagen, and TUNEL of Matricaria recutita L. extract and triamcinolone on oral ulcer in diabetic rats. J Appl Oral Sci. 2016;24:278\u201390.","journal-title":"J Appl Oral Sci"},{"key":"3886_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/00220345211024528","volume":"101","author":"X Qi","year":"2022","unstructured":"Qi X, Lin W, Wu Y, Li Q, Zhou X, Li H, et al. CBD promotes oral ulcer healing via inhibiting CMPK2-mediated inflammasome. J Dent Res. 2022;101:206\u201315.","journal-title":"J Dent Res"},{"key":"3886_CR19","unstructured":"Health Products Regulatory Authority. Cannabis for medical use - a scientific review. Available from: https:\/\/www.hpra.ie\/docs\/default-source\/publications-forms\/newsletters\/cannabis-for-medical-use---a-scientific-review.pdf. Accessed 3 Jul 2022."},{"key":"3886_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"C MacCallum","year":"2018","unstructured":"MacCallum C, Rosso E. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139.","journal-title":"Eur J Intern Med"},{"key":"3886_CR21","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1007\/s00520-022-07312-y","volume":"30","author":"SW Nielsen","year":"2022","unstructured":"Nielsen SW, Hasselsteen SD, Dominiak HSH, Labudovic D, Reiter L, Dalton SO, et al. Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2022;30:9441\u201351.","journal-title":"Support Care Cancer"},{"key":"3886_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","volume":"6","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, Queiroz RH, Zuardi AW, Crippa JA. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011;6:237\u201349.","journal-title":"Curr Drug Saf"},{"key":"3886_CR23","unstructured":"Meissner H, Cascella M. Cannabidiol (CBD). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556048\/. Accessed 7 Aug 2022."},{"key":"3886_CR24","first-page":"287","volume":"50","author":"DS Wilkinson","year":"1970","unstructured":"Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, Cronin E, et al. Terminology of contact dermatitis. Acta Derm Venereol. 1970;50:287\u201392.","journal-title":"Acta Derm Venereol"},{"key":"3886_CR25","first-page":"159","volume":"22","author":"D Ofluoglu","year":"2017","unstructured":"Ofluoglu D, Ergun S, Warnakulasuriya S, Namdar-Pekiner F, Tanyeri H. An evaluation of the efficacy of a topical gel with triester glycerol oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: a randomized, double-blind, placebo-controlled clinical trial. Med Oral Patol Oral Cir Bucal. 2017;22:159\u201366.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"3886_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/jop.12059","volume":"42","author":"AR Tappuni","year":"2013","unstructured":"Tappuni AR, Kovacevic T, Shirlaw PJ, Challacombe SJ. Clinical assessment of disease severity in recurrent aphthous stomatitis. J Oral Pathol Med. 2013;42:635\u201341.","journal-title":"J Oral Pathol Med"},{"key":"3886_CR27","first-page":"1","volume":"10","author":"P Barnes","year":"2008","unstructured":"Barnes P, Bloom B, Nahin R. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;10:1\u201323.","journal-title":"Natl Health Stat Report"},{"key":"3886_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6626394","volume":"2021","author":"H Ashraf","year":"2021","unstructured":"Ashraf H, Salehi A, Sousani M, Sharifi M. Use of complementary alternative medicine and the associated factors among patients with depression. Evid Based Complement Alternat Med. 2021;2021:1\u20138.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3886_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000510986","volume":"28","author":"M Seyed Hashemi","year":"2021","unstructured":"Seyed Hashemi M, Namiranian N, Tavahen H, Dehghanpour A, Rad MH, Jam-Ashkezari S, et al. Efficacy of pomegranate seed powder on glucose and lipid metabolism in patients with type 2 diabetes: a prospective randomized double-blind placebo-controlled clinical trial. Complement Med Res. 2021;28:226\u201333.","journal-title":"Complement Med Res"},{"key":"3886_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/bfm.2018.0032","volume":"13","author":"S Ketsuwan","year":"2018","unstructured":"Ketsuwan S, Baiya N, Paritakul P, Laosooksathit W, Puapornpong P. Effect of herbal compresses for maternal breast engorgement at postpartum: a randomized controlled trial. Breastfeed Med. 2018;13:361\u20135.","journal-title":"Breastfeed Med"},{"key":"3886_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.34172\/jhp.2021.19","volume":"10","author":"I Wahyuni","year":"2021","unstructured":"Wahyuni I, Sufiawati I, Nittayananta W, Puspitasari I, Levita J. Efficacy and safety of plant-based therapy on recurrent aphthous stomatitis and oral mucositis in the past decade: a systematic review. J Herbmed Pharmacol. 2021;10:179\u201387.","journal-title":"J Herbmed Pharmacol"},{"key":"3886_CR32","unstructured":"Stone WL, Basit H, Burns B. Pathology, inflammation. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534820\/. Accessed 12 May 2022."},{"key":"3886_CR33","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/ptr.6165","volume":"32","author":"M Klein","year":"2018","unstructured":"Klein M, Bortolli J, Guimar\u00e3es F, Salum F, Cherubini K, Figueiredo M. Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: clinical and histological evaluation. Phytother Res. 2018;32:2275\u201381.","journal-title":"Phytother Res"},{"key":"3886_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1034\/j.1600-0722.2003.00057.x","volume":"111","author":"C Llewellyn","year":"2003","unstructured":"Llewellyn C, Warnakulasuriya S. The impact of stomatological disease on oral health-related quality of life. Eur J Oral Sci. 2003;111:297\u2013304.","journal-title":"Eur J Oral Sci"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-03886-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:04:04Z","timestamp":1676883844000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-03886-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3886"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-03886-0","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"21 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was performed with informed consent following protocols approved by the Human Research Ethics Committee of the Faculty of Dentistry, Chulalongkorn University (certificate number HREC-DCU 2021\u2013048 approved on 9 July 2021). Informed consent was obtained from all subjects. All methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}